Sanofi SA (SNY)
46.68
-1.00
(-2.10%)
USD |
NASDAQ |
Apr 24, 16:00
46.68
0.00 (0.00%)
After-Hours: 20:00
Sanofi Profit Margin (Quarterly): -4.55% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -4.55% |
| September 30, 2023 | 19.88% |
| June 30, 2023 | 13.43% |
| March 31, 2023 | 18.37% |
| December 31, 2022 | 27.16% |
| September 30, 2022 | 15.80% |
| June 30, 2022 | 10.94% |
| March 31, 2022 | 19.98% |
| December 31, 2021 | 11.03% |
| September 30, 2021 | 21.33% |
| June 30, 2021 | 13.24% |
| March 31, 2021 | 17.62% |
| June 30, 2020 | 90.04% |
| March 31, 2020 | 18.07% |
| December 31, 2019 | -0.62% |
| September 30, 2019 | 17.80% |
| June 30, 2019 | -0.97% |
| March 31, 2019 | 13.05% |
| December 31, 2018 | 2.72% |
| September 30, 2018 | 23.34% |
| June 30, 2018 | 8.98% |
| March 31, 2018 | 12.50% |
| December 31, 2017 | 1.23% |
| September 30, 2017 | 16.68% |
| June 30, 2017 | 11.61% |
| Date | Value |
|---|---|
| March 31, 2017 | 64.08% |
| December 31, 2016 | 8.62% |
| September 30, 2016 | 18.01% |
| June 30, 2016 | 13.94% |
| March 31, 2016 | 13.71% |
| December 31, 2015 | 4.89% |
| September 30, 2015 | 16.82% |
| June 30, 2015 | 14.86% |
| March 31, 2015 | 12.45% |
| December 31, 2014 | 18.97% |
| September 30, 2014 | 13.42% |
| June 30, 2014 | 9.54% |
| March 31, 2014 | 13.68% |
| December 31, 2013 | 16.23% |
| September 30, 2013 | 14.31% |
| June 30, 2013 | 5.54% |
| March 31, 2013 | 12.12% |
| December 31, 2012 | 4.47% |
| September 30, 2012 | 16.66% |
| June 30, 2012 | 12.65% |
| March 31, 2012 | 20.24% |
| December 31, 2011 | 15.60% |
| September 30, 2011 | 22.13% |
| June 30, 2011 | 11.47% |
| March 31, 2011 | 14.87% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-4.55%
Minimum
Dec 2023
90.04%
Maximum
Jun 2020
18.15%
Average
17.62%
Median
Mar 2021
Profit Margin (Quarterly) Benchmarks
| AstraZeneca PLC | 7.98% |
| GSK PLC | 4.35% |
| Novo Nordisk A/S | 33.35% |
| Regeneron Pharmaceuticals Inc | 33.77% |
| Inhibrx Inc | -5.73K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 7.42% |
| Return on Assets | 4.27% |
| Return on Invested Capital | 5.84% |
| Gross Profit Margin (Quarterly) | 66.82% |
| Operating Margin (Quarterly) | 16.02% |
| Return on Net Operating Assets | 5.03% |